Stevanato Group S.p.A. $STVN Stock: Conestoga Capital Advisors LLC Decreases Position

Stevanato Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Conestoga Capital Advisors cut its Stevanato Group stake by 20.1%, selling about 1.41 million shares in the third quarter; it still held 5.60 million shares, worth roughly $117.4 million.
  • Third-quarter revenue increased 8% to €326.1 million, but EPS of €0.16 narrowly missed the €0.17 consensus estimate.
  • Management expects low-single-digit growth in 2027 amid weaker GLP-1 syringe volumes, while analysts including UBS and William Blair lowered their outlooks for the stock.
  • Five stocks we like better than Stevanato Group.

Conestoga Capital Advisors LLC decreased its stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 20.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,596,515 shares of the company's stock after selling 1,411,098 shares during the period. Stevanato Group accounts for about 3.6% of Conestoga Capital Advisors LLC's holdings, making the stock its 7th biggest position. Conestoga Capital Advisors LLC owned about 1.85% of Stevanato Group worth $117,415,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Wellington Management Group LLP purchased a new stake in shares of Stevanato Group during the 2nd quarter worth approximately $22,621,000. Ranger Investment Management L.P. purchased a new position in Stevanato Group in the second quarter valued at approximately $21,438,000. Cooper Investors PTY Ltd. grew its holdings in Stevanato Group by 4.4% during the second quarter. Cooper Investors PTY Ltd. now owns 668,494 shares of the company's stock valued at $12,080,000 after purchasing an additional 28,265 shares during the period. Schwartz Investment Counsel Inc. raised its stake in shares of Stevanato Group by 15.0% in the third quarter. Schwartz Investment Counsel Inc. now owns 661,136 shares of the company's stock valued at $13,871,000 after buying an additional 86,385 shares during the period. Finally, Fenimore Asset Management Inc bought a new stake in shares of Stevanato Group in the third quarter valued at $12,212,000.

Stevanato Group News Summary

Here are the key news stories impacting Stevanato Group this week:

  • Positive Sentiment: Third-quarter revenue rose 8% to €326.1 million. However, reported EPS was slightly below the consensus estimate in one earnings summary. Stevanato Group Q3 results
  • Neutral Sentiment: Citigroup lowered its price target from $26 to $20 but kept a Buy rating, signaling reduced expectations while remaining positive on the shares. Citigroup price target update
  • Negative Sentiment: Management said GLP-1-related revenue declined in Q3 to about 17%–18% of total revenue. The company also expects only low-single-digit growth in 2027, amid lower GLP-1 syringe volumes linked to one customer. 2027 growth outlook and GLP-1 volumes
  • Negative Sentiment: UBS cut its price target from $23 to $16 and maintained a Neutral rating; William Blair downgraded the stock from Outperform to Market Perform. UBS price target update William Blair downgrade
  • Negative Sentiment: Several law firms announced investigations into whether Stevanato complied with securities laws, following its GLP-1 revenue disclosure. These are investigations, not findings of wrongdoing, but may add legal and reputational uncertainty. Investor investigation announcement

Insider Buying and Selling

In other news, Director Luciano Santel sold 2,023 shares of the firm's stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of €20.09, for a total value of €40,642.07. Following the transaction, the director owned 4,739 shares in the company, valued at approximately €95,206.51. This trade represents a 29.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Mauro Stocchi sold 13,649 shares of Stevanato Group stock in a transaction on Monday, September 28th. The stock was sold at an average price of €21.50, for a total transaction of €293,453.50. Following the completion of the transaction, the insider directly owned 400,000 shares in the company, valued at approximately €8,600,000. The trade was a 3.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 21,926 shares of company stock worth $459,738. 0.70% of the stock is owned by company insiders.

Analyst Ratings Changes

STVN has been the topic of a number of research reports. Weiss Ratings upgraded Stevanato Group from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, August 27th. UBS Group cut their target price on shares of Stevanato Group from $23.00 to $16.00 and set a "neutral" rating for the company in a research report on Wednesday. William Blair downgraded shares of Stevanato Group from an "outperform" rating to a "market perform" rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft began coverage on shares of Stevanato Group in a research note on Wednesday, October 7th. They issued a "hold" rating for the company. Finally, Citigroup lowered their price target on shares of Stevanato Group from $26.00 to $20.00 and set a "buy" rating on the stock in a research report on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy".

Get Our Latest Report on STVN

Stevanato Group Stock Down 1.2%

Shares of NYSE:STVN opened at €13.29 on Thursday. The stock has a market capitalization of $4.02 billion, a P/E ratio of 22.91, a price-to-earnings-growth ratio of 1.16 and a beta of 0.80. The stock's 50-day moving average price is €20.17 and its 200-day moving average price is €18.07. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21. Stevanato Group S.p.A. has a 12-month low of €12.05 and a 12-month high of €27.00.

Stevanato Group (NYSE:STVN - Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported €0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.17 by (€0.01). The company had revenue of €326.06 million for the quarter. Stevanato Group had a return on equity of 10.62% and a net margin of 11.24%. On average, equities analysts anticipate that Stevanato Group S.p.A. will post 0.69 earnings per share for the current year.

About Stevanato Group

(Free Report)

Stevanato Group S.p.A. is an Italy-based provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and healthcare industries. Founded in 1949, the company has developed from a glass-packaging manufacturer into an integrated supplier serving customers throughout the global pharmaceutical supply chain.

The company manufactures primary packaging products, including glass vials, syringes, cartridges and ampoules, as well as components and systems used to contain and administer injectable medicines.

Featured Articles

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN - Free Report).

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines